e.l.f. Beauty Stock Is Off to a Hot Start to 2026. Will It Continue?

e.l.f. Beauty reported resilient top-line growth with sales up 14% to $343.9 million for the period ending Sept. 30, 2025, while gross margin compressed 165 bps to 69% primarily due to tariffs and SG&A rose 24%, driving reported profit down about 84% to roughly $3 million (year-ago ~$19 million); adjusted earnings fell by under 10% after acquisition and one-time charges. The shares, which plunged nearly 40% last year amid tariff concerns, have rebounded ~17% year-to-date (as of Jan. 26) and trade at roughly 27x forward earnings; a favorable court ruling striking tariffs could be a material upside catalyst for the stock.

Analysis

Market structure: ELF sits squarely as a beneficiary if US/administrative tariffs on cosmetic imports are struck down — immediate margin recovery could be 100–300 bps depending on product mix, boosting forward EPS and justifying a rerating from 27x to 30–35x if growth sustains ~10–15% annual revenue. Losers would be importers that cannot pass costs to consumers and competitors with thinner gross margins; retailers selling premium-priced cosmetics (higher ASPs) may see relative demand shift toward value brands. Cross-asset: a legal win would be equity-positive, tighten credit spreads for retail names and likely depress near-term implied vols; FX/commodity impact is immaterial except for USD-sensitive input costs if supply chains re-shore.

Risk assessment: Key tail risks include a court upholding tariffs (large margin compression, 100–300 bps) or multi-quarter SG&A inflation continuing (>20% YoY) that keeps adjusted EPS negative for two quarters. Timeframes: immediate (days-weeks) = volatility around legal filings/earnings; short-term (1–3 months) = pricing adjustments and promotional activity; long-term (6–24 months) = brand penetration with Gen-Z and margin normalization. Hidden dependencies: ELF’s resilience hinges on ability to maintain promotional cadence without further margin erosion and on suppliers’ willingness to absorb or defer costs.

Trade implications: Direct long ELF exposure is asymmetric vs legal catalyst — equity rally if tariffs removed, but downside if tariffs persist. Use option structures to express binary legal outcome while limiting downside; implied vol will spike into legal/earnings events so cost-efficiency matters. Relative plays: short higher-end peers that rely less on value positioning and have less pricing power if consumer spends reallocate to budget cosmetics.

Contrarian angles: The market may underprice persistent SG&A/one-time acquisition drags — GAAP profit swung massively while adjusted EPS fell <10%, suggesting earnings leverage is intact once one-offs roll off. Conversely, consensus may also under-appreciate a sustained re-shoring cost that keeps tariffs-like margins even if tariffs are removed. Historical parallel: prior tariff reversals (consumer durables) produced quick re-ratings within 3–6 months; but competition and margin pass-through varied and reduced the long-term upside in ~12–24 months.

Key Decisions for Investors

• Establish a 2–3% long position in ELF (NYSE: ELF) on a 12–18 month horizon; set a profit target of +40–60% or re-evaluate if forward P/E expands above 35x. Use a hard stop-loss at -18% to limit exposure to adverse legal outcomes.
• If a favorable court ruling is scheduled within the next 60–120 days, deploy a directional options trade: buy 6–9 month call spreads (long ~25% OTM, short ~45% OTM) sized to 0.5–1% of portfolio to capture catalytic upside while capping premium outlay.
• Implement a relative-value pair: long ELF (2%) vs short Estee Lauder (EL) or Ulta Beauty (ULTA) (1–1.5%) for 6–12 months to play value-segment resilience vs premium cyclical exposure; rebalance if the spread tightens/widens >20%.
• If ELF reports another quarter with adjusted EPS down >10% YoY or management signals sustained SG&A inflation >15% YoY, reduce ELF exposure to <0.5% and rotate 1–2% into defensive staples ETF (XLP) until margins visibly normalize.